We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Latest News

This image shows immune cells responding to the senescent cancer cells used as a vaccine.

Senescent Cell “Vaccine” Reduces Tumor Development in Cancer Models

Researchers have used senescent cells as a "vaccine" that can be used as a prophylaxis and a therapeutic to prime the immune system against cancer cells, which has shown positive results in cancer models.
Cut-side-up halved citrus fruits.

Vitamin C Could Enhance Immune System-Based Cancer Treatment

New research has shown that vitamin C can enhance the immunogenic properties of dendritic cells, a cell type that could be used as an anticancer therapy.
A person receives a vaccination.

Getting “To the Heart” of Cardiovascular Risks Post-COVID-19 Vaccination

A meta-analysis of cardiovascular reactions in people under 40 following COVID-19 vaccination aims to clarify the risks of vaccines and contribute to a safer vaccination strategy for high-risk individuals.
An image showing a cell and its nucleus.

A New Way To Fine-Tune How Much Protein a Cell Produces

Using an approach based on CRISPR proteins, MIT researchers have developed a new way to precisely control the amount of a particular protein that is produced in mammalian cells.
A diagram of an antibody drug called CIS43LS preventing malaria infection by interrupting the lifecycle of the Plasmodium falciparum parasite. The antibody binds to and neutralizes sporozoites, the stage of the parasite transmitted from mosquitos to humans.

Monoclonal Antibody Protects Against Malaria Infection in Mali Clinical Trial

In a clinical trial, a monoclonal antibody safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa.
Two syringes on a yellow background.

Key Differences in the Immune Responses to SARS-CoV-2 Vaccines

Researchers have characterized the different immune responses to inactivated virus vaccines and to mRNA vaccines.
An outline of a brain with the blood vessels shown in red.

Why Shingles Can Sometimes Cause Strokes

Shingles can increase the risk of stroke for a year after infection, and researchers have identified how in a new study.
An incomplete jigsaw puzzle showing an image of three strands of DNA.

Proteins “Slide” Genetic Instructions Into Cell in New Gene Therapy Approach

Researchers may have developed a new method for targeting specific cell types for a variety of disorders that could be treated with gene therapies.
A doctor administers a nasal vaccine.

Nasal Vaccine Bolsters Immune Responses to COVID-19 in Vaccinated Animals

A new "prime and spike" vaccine approach that uses a nasal vaccine to boost the immune response after intramuscular vaccination has been shown to be effective in animals.
A stylised image of an antibody.

Antibody Therapy Shows Promise Against Epstein-Barr Virus in Human Cells

Researchers have identified "sites of vulnerability" on the surface of the Epstein-Barr virus and have designed a panel of experimental monoclonal antibody therapies to prevent or treat EBV infection.